2009
DOI: 10.1111/j.1365-2133.2008.08961.x
|View full text |Cite
|
Sign up to set email alerts
|

Autoantibodies against type XVII collagen C-terminal domain in a patient with bullous pemphigoid associated with psoriasis vulgaris

Abstract: effect of reproductive hormones on skin disorders have been somewhat hampered, however, by the fact that individual patient sensitivity varies widely and by a body of research that has employed diverse research parameters, such as dosage, testing sites, concentration, vehicle of irritant delivery, and method of assessment. Further research, with strict attention to standardizing experimental parameters and limiting compounding factors, will help to elucidate the biochemical basis for the observed effects of pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 11 publications
(15 reference statements)
0
1
0
Order By: Relevance
“…However, the deficiencies in the evidence were clear to see: many trials are still relatively short with clinical and methodological heterogeneity, lack of effective treatments for nail psoriasis and PPP, a need for long‐term safety trials for various agents including potent and superpotent topical corticosteroids, as well as combination of biologics with phototherapy or other systemic treatments, and routine assessment of quality of life in trials with topical treatments. Numerous publications are currently produced in this field and it is hoped that with the aid of the Evidence Based Update Meeting and similar steering meetings the above deficiencies might be adequately addressed in due course 72–163 . The feedback from the delegates was very positive: 60% said the meeting was extremely useful and 39% useful.…”
Section: Discussionmentioning
confidence: 99%
“…However, the deficiencies in the evidence were clear to see: many trials are still relatively short with clinical and methodological heterogeneity, lack of effective treatments for nail psoriasis and PPP, a need for long‐term safety trials for various agents including potent and superpotent topical corticosteroids, as well as combination of biologics with phototherapy or other systemic treatments, and routine assessment of quality of life in trials with topical treatments. Numerous publications are currently produced in this field and it is hoped that with the aid of the Evidence Based Update Meeting and similar steering meetings the above deficiencies might be adequately addressed in due course 72–163 . The feedback from the delegates was very positive: 60% said the meeting was extremely useful and 39% useful.…”
Section: Discussionmentioning
confidence: 99%